Award recordCONTRACT

GENZYME CORPORATION

PIID 36C26222F0606· VHA· 262-NETWORK CONTRACT OFFICE 22 (36C262)· 6505 · DRUGS AND BIOLOGICALS· FY2022· $20,049 net obligations· UEI X2XMAQLR9DA8· MA

Description

EMERGENCY PHARMACEUTICAL ORDER OF ELIGLUSTAT CERDELGA 84MG

First action · last action
2022-09-14 · 2022-09-14
Transactions
1
First transaction's obligation
$20,049
Base + all options value (sum of deltas)
$20,049
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79719D0153
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 1 transaction

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$20,049$0Base award · 2022-09-14 · this action $20,049 · running total $20,049
  • Base2022-09-14+$20,049= $20,049
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2022-09-14+$20,049$20,049EMERGENCY PHARMACEUTICAL ORDER OF ELIGLUSTAT CERDELGA 84MG

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI X2XMAQLR9DA8)

AwardOffice · PSC / listingNet obligationsFY
36E79724A0018NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36C26124N0260261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$11,882FY2024
36C26023F0186260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$144,553FY2023
36C26223F0045262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$246,001FY2023
36C26223F0022262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$266,652FY2023
36C26022F0171260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$241,190FY2022

Other recipients under 6505 from 262-NETWORK CONTRACT OFFICE 22 (36C262) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26226N0873CENTRAL ADMIXTURE PHARMACY SERVICES, INC262-NETWORK CONTRACT OFFICE 22 (36C262)$140,823FY2026
36C26226N0871CENTRAL ADMIXTURE PHARMACY SERVICES, INC262-NETWORK CONTRACT OFFICE 22 (36C262)$231,746FY2026
36C26226N0870CENTRAL ADMIXTURE PHARMACY SERVICES, INC262-NETWORK CONTRACT OFFICE 22 (36C262)$167,369FY2026
36C26226N0872CENTRAL ADMIXTURE PHARMACY SERVICES, INC262-NETWORK CONTRACT OFFICE 22 (36C262)$164,265FY2026
36C26226P1412ASD SPECIALTY HEALTHCARE, LLC262-NETWORK CONTRACT OFFICE 22 (36C262)$38,220FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26222F0606_3600_36F79719D0153_3600 · retrieved 2026-09-26.